Vaxart (VXRT) Cash & Equivalents (2010 - 2026)
Vaxart (VXRT) reported Cash & Equivalents of $50.93 million for Q2 2026, up 153.2% from $20.11 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Vaxart posted Cash & Equivalents of $53.81 million, up 113.3% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $25.23 million in FY2024 (-27.4%), $34.76 million in FY2023 (-24.5%), $46.01 million in FY2022 (-68.0%) and $143.75 million in FY2021 (+13.3%).
- Five-year quarterly Cash & Equivalents spans a low of $16.88 million in Q3 2025 and a high of $167.23 million in Q3 2021.
- Year over year, Cash & Equivalents has now increased in each of the last three quarters, with growth averaging 26.6% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2026 (growth of 153.2%); the low point was Q3 2022 (a decline of 69.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $50.75 million (Q1 2026), $53.81 million (Q4 2025) and $16.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.26 Bn | 1,101.85 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.92 Bn | 555.78 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 506.32 Bn | 479.44 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.38 Bn | 312.76 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 293.00 Bn | 256.99 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.76 Bn | 239.44 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.88 Bn | 193.27 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.26 Bn | 169.45 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.34 Bn | 117.99 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Vaxart | 101.71 Mn | 37.71 Mn | - | 50.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.93 Mn |
| Mar 31, 2026 | 50.75 Mn |
| Dec 31, 2025 | 53.81 Mn |
| Sep 30, 2025 | 16.88 Mn |
| Jun 30, 2025 | 20.11 Mn |
| Mar 31, 2025 | 28.70 Mn |
| Dec 31, 2024 | 25.23 Mn |
| Sep 30, 2024 | 22.04 Mn |
| Jun 30, 2024 | 43.29 Mn |
| Mar 31, 2024 | 26.74 Mn |
| Dec 31, 2023 | 34.76 Mn |
| Sep 30, 2023 | 33.24 Mn |
| Jun 30, 2023 | 43.28 Mn |
| Mar 31, 2023 | 48.43 Mn |
| Dec 31, 2022 | 46.01 Mn |
| Sep 30, 2022 | 50.77 Mn |
| Jun 30, 2022 | 91.47 Mn |
| Mar 31, 2022 | 123.40 Mn |
| Dec 31, 2021 | 143.75 Mn |
| Sep 30, 2021 | 167.23 Mn |
API Access
Vaxart Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();